NVGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Novogen Ltd's enterprise value is $6.60 Mil. Novogen Ltd's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2015 was $-5.14 Mil. Therefore, Novogen Ltd's EV/EBITDA ratio for today is -1.28.
During the past 13 years, the highest EV/EBITDA Ratio of Novogen Ltd was 0.40. The lowest was -47.10. And the median was -3.50.
EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.
The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.
Novogen Ltd's EV/EBITDA for today is calculated as:
|EV/EBITDA||=||Enterprise Value (Today)||/||Earnings Before Depreciation and Amortization (TTM)|
Novogen Ltd's current Enterprise Value is $6.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novogen Ltd's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2015 was $-5.14 Mil.
Novogen Ltd's P/E Ratio for today is calculated as:
Novogen Ltd's share price for today is $1.98.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novogen Ltd's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2015 was $-0.58.
Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.
Novogen Ltd Annual Data
Novogen Ltd Semi-Annual Data